Psychemedics FY2021 revenue up 17% to $24.9M; net loss narrows to $0.7M from $3.9M

PSYCHEMEDICS CORP

Full-year revenue $24.9M (+17% YoY); net loss $0.7M ($0.12/diluted) vs $3.9M ($0.70) loss in 2020.
Q4 revenue $6.4M (+21% YoY) but Q4 net loss widened to $1.6M ($0.29/diluted) from $0.5M ($0.10).
PPP loan of $2.2M forgiven; $2.6M employee retention credits recognized; $3.3M in legal settlement charges.
Resumed quarterly dividend in Q4 2021 after pandemic suspension; board to evaluate future dividends.
Exploring strategic alternatives; year-end cash $2.0M, working capital $4.5M, equipment debt $1.3M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.